ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,332Medicare Part D Prescriptions Filled, Including Refills

Rank: 133 out of 1456

$697K Total Retail Price of All Prescriptions

Rank: 268 out of 1456

497 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 497 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

17% of this provider’s 497 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 16,171 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
LISINOPRIL 765 752 1 3
FUROSEMIDE 660 645 2 7
DONEPEZIL HCL 538 538 3 29
LEVOTHYROXINE SODIUM 503 494 4 4
AMLODIPINE BESYLATE 495 443 5 1
NAMENDA 471 471 6 38
SIMVASTATIN 464 430 7 2
HYDROCODONE-ACETAMINOPHEN 430 358 S3 8 6
METFORMIN HCL 404 398 9 8
HYDROCHLOROTHIAZIDE 397 379 10 10
METOPROLOL TARTRATE 387 383 11 12
SERTRALINE HCL 387 381 11 25
TRAMADOL HCL 376 368 13 17
LOVASTATIN 327 304 14 40
OMEPRAZOLE 310 296 15 5
MIRTAZAPINE 302 290 16 65
RISPERIDONE 268 254 17 72
METOPROLOL SUCCINATE 241 240 18 19
FAMOTIDINE 226 226 19 45
CITALOPRAM HBR 220 214 20 22
RANITIDINE HCL 220 188 20 27
TRIAMTERENE-HCTZ 217 192 22 49
POTASSIUM CHLORIDE 215 214 23 15
GABAPENTIN 212 117 24 13
FLUTICASONE PROPIONATE 175 167 25 28
NIFEDIPINE ER 162 162 26 81
CARVEDILOL 161 152 27 20
ATENOLOL 156 120 28 18
ATORVASTATIN CALCIUM 152 152 29 11
METHADONE HCL 147 86 S2 30 190
PREDNISONE 143 135 31 42
WARFARIN SODIUM 143 143 31 21
DIGOXIN 142 110 33 62
LOSARTAN POTASSIUM 138 138 34 16
LISINOPRIL-HYDROCHLOROTHIAZIDE 124 108 35 24
ZOLPIDEM TARTRATE 120 117 36 14
PRAVASTATIN SODIUM 110 108 37 9
KLOR-CON 10 109 97 38 96
NEXIUM 109 108 38 23
FLUOXETINE HCL 108 69 40 55
ALLOPURINOL 108 108 40 31
PLAVIX 106 100 42 46
DIOVAN 93 93 43 35
GLIPIZIDE 90 69 44 53
HYDRALAZINE HCL 86 86 45 48
DOXAZOSIN MESYLATE 85 85 46 84
NAPROXEN 84 84 47 100
LEVOFLOXACIN 81 77 48 79
KETOCONAZOLE 80 67 49 241
SEROQUEL 79 79 50 154
ADVAIR DISKUS 74 73 51 63
ALENDRONATE SODIUM 73 67 52 36
CLONIDINE HCL 72 72 53 39
EVISTA 69 65 54 113
ISOSORBIDE MONONITRATE ER 68 68 55 60
CARBIDOPA-LEVODOPA 68 68 55 141
MORPHINE SULFATE ER 66 54 S2 57 173
AZITHROMYCIN 64 60 58 44
OXYCODONE-ACETAMINOPHEN 63 42 S2 59 109
CLOPIDOGREL 62 56 60 32
CYMBALTA 61 56 61 52
LEVETIRACETAM 60 28 62 97
TRIAMCINOLONE ACETONIDE 59 58 63 158
TRIAMTERENE-HYDROCHLOROTHIAZID 58 50 64 201
NITROGLYCERIN PATCH 58 58 64 178
BACLOFEN 58 33 64 168
GLIMEPIRIDE 56 56 67 33
VALPROIC ACID 56 24 67 230
LOSARTAN-HYDROCHLOROTHIAZIDE 56 46 67 41
FLUOCINONIDE 56 56 67 314
BUPROPION HCL SR 56 52 67 185
KLOR-CON M10 54 39 72 140
DIVALPROEX SODIUM 54 42 72 108
GLIPIZIDE ER 54 54 72 86
PROAIR HFA 54 41 72 69
HYDROXYCHLOROQUINE SULFATE 52 52 76 217
DIVALPROEX SODIUM ER 52 50 76 227
PAROXETINE HCL 51 51 78 67
PROPRANOLOL HCL 51 46 78 143
LANTUS 50 50 80 50
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.